Lv11
50 积分 2026-03-27 加入
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial
1小时前
待确认
Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial
1个月前
已完结
Selective Elimination of Breast Surgery for Invasive Breast Cancer
1个月前
已完结
皖公网安备34019202002308
